Wearable light-operated controlled-release drug delivery device for temporomandibular joint treatment

Abstract

The wearable light-operated controlled-release drug delivery device for temporomandibular joint treatment comprises a wearable head clamp worn on the head of a patient, a connecting reed is fixedly installed on the upper surface of the wearable head clamp, and the wearable head clamp is divided into a first clamping rod and a second clamping rod which are symmetrical to each other; and control boxes are installed on the side faces of the first clamping rod and the second clamping rod correspondingly, operation keys and photosensitive sensors are fixedly installed on the outer surfaces of the control boxes, and the photosensitive sensors and intelligent control systems in the control boxes are controlled in a matched mode. According to the wearable light-operated controlled-release drug delivery device for temporomandibular joint treatment, the photosensitive sensor is arranged on the outer surface of the control box, surrounding light intensity can be sensed through the photosensitive sensor, so that whether the day or night is judged, the photosensitive sensor transmits signals to the control chip, and the control chip is used for automatically controlling the delivery pump to deliver drugs; the dosage is high during daytime, the dosage is weak during night, the dosage is reduced, and the optimal treatment effect is finally achieved.

Description

Technical Field

[0001] The present invention relates to the technical field of temporomandibular joint treatment, and in particular to a wearable light-controlled controlled-release drug delivery device for treating temporomandibular joint. Background Art

[0002] The temporomandibular joint (TMJ) is a crucial joint connecting the mandible and temporal bone, located below the skull, in front of the ear. This joint is crucial for chewing, speaking, and various jaw movements. Following surgery for a TMJ injury, patients require continuous medication to aid recovery.

[0003] In the prior art, Chinese patent application number CN202210601580.4 discloses a wearable light-controlled microneedle drug delivery device for treating the temporomandibular joint. The device proposes the following technical solution: it includes a U-shaped neck ring with support shields connected to both ends of the U-shaped neck ring, two jaw mask components arranged on one side near the two support plates, microneedles installed on the inner sides of the two jaw mask components, and an infrared LED lamp used in conjunction with the microneedles. The microneedles are formed by hyaluronic acid and a drug-carrying material for light-controlled release treatment of osteoarthritis. After the microneedle drug solution penetrates the skin surface, it begins to dissolve under the action of the body's hyaluronidase, allowing the drug-carrying material for light-controlled release treatment of osteoarthritis to enter the body. Under near-infrared light irradiation, anti-inflammatory drugs and lubricants are released to achieve the purpose of reducing the number of treatments and effectively treating inflammation and relieving pain. The outer surface of the microneedle has a lubricating coating, which allows the microneedle to enter the skin without resistance, reducing friction when the microneedle enters the skin, and achieving minimally invasive and painless treatment.

[0004] For example, in the prior art, a Chinese patent with application number CN202322980618.6 discloses a guide plate for injection treatment of the upper cavity of the temporomandibular joint, which belongs to the field of injection treatment devices for the upper cavity of the temporomandibular joint. It includes a connecting rod, an occlusal plate for tooth occlusion, and a needle insertion fixing plate for positioning the upper cavity of the temporomandibular joint. The occlusal plate and the needle insertion fixing plate are connected by a connecting rod. The needle insertion fixing plate is provided with a needle insertion positioning guide column corresponding to the position of the upper cavity of the temporomandibular joint. The needle insertion positioning guide column is provided with a needle insertion positioning hole. The guide plate can accurately locate the position of the upper cavity of the temporomandibular joint through the cooperation of the occlusal plate and the needle insertion fixing plate, thereby achieving accurate determination of the needle insertion depth and direction, avoiding deviation in the needle insertion depth and direction, and reducing the damage and complications of repeated needle insertion.

[0005] For example, in the prior art, the Chinese patent with application number CN202021526750.X discloses an oral care applicator, including a connecting block; upper and lower alveoli are respectively provided on both sides of the connecting block; external support blocks are provided on the outer sides of the upper and lower alveoli; an adjustment strip hole is provided on the connecting block; a universal joint is provided in the adjustment strip hole; a drug delivery tube is provided through the universal joint; a scissors-type lifting mechanism is provided between the upper and lower alveoli; one end of the drug delivery tube is connected to the injection head, and the other end is provided with a drug delivery tray; a liquid outlet is provided on the drug delivery tray, which supports the patient's upper and lower jaws through the upper and lower alveoli and the cooperating groove body, without the patient's own muscle force, and can ensure that the patient will not experience muscle soreness when opening his mouth to apply medicine for a long time, avoiding the problem of difficulty in applying medicine due to muscle trembling. The scissors-type lifting mechanism can adjust the distance between the upper and lower alveoli to adapt to different types of oral opening and closing.

[0006] Combined with the above materials, it can be seen that the drug delivery devices in the prior art are generally administered by injection. However, in actual use, the drug delivery devices in the above devices all require manual operation and control, which cannot be operated when the patient is sleeping at night, resulting in the inability to continuously deliver the drug, thereby affecting the overall treatment effect. Summary of the Invention

[0007] The object of the present invention is to provide a wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint, so as to solve the problem of inconvenience in automatic operation raised in the above-mentioned background technology.

[0008] To achieve the above-mentioned objectives, the present invention provides the following technical solutions: a wearable light-controlled controlled-release drug delivery device for the treatment of temporomandibular joints, comprising a wearable head clamp worn on the patient's head, a connecting spring fixedly installed on the upper surface of the wearable head clamp, the wearable head clamp is divided into a first clamping rod and a second clamping rod that are symmetrical to each other, and a control box is installed on the side of the first clamping rod and the second clamping rod, and an operation button and a light-sensitive sensor are fixedly installed on the outer surface of the control box, the light-sensitive sensor cooperates with the intelligent control system inside the control box for control, a lithium battery for powering other components is fixedly installed on the upper end of the control box, and a charging port for charging the lithium battery is provided on the upper surface of the control box, and an installation slot is provided at the lower end of the control box, a storage tank for storing medicine is installed inside the installation slot; a first connecting tube is fixedly installed on the outside of the control box, and a drug delivery device corresponding to the position of the patient's jaw joint is fixedly installed on the lower end of the first connecting tube, and injection microneedles arranged in a matrix are fixedly installed on the outside of the drug delivery device.

[0009] Preferably, the intelligent control system includes a delivery pump, a control chip and a signal transmitter fixedly installed inside the control box, and the water outlet end of the delivery pump is fixedly connected to the first connecting pipe.

[0010] Preferably, the photosensor and the delivery pump communicate with each other through the cable and the control chip, and the signal transmitter communicates with the wireless terminal through 5G signals, and the wireless terminal is the patient's personal mobile phone.

[0011] Preferably, a connector corresponding to the mounting slot is fixedly installed in the middle position inside the control box, and the connector is connected to the water inlet end of the delivery pump through a second connecting pipe at its upper end.

[0012] Preferably, an extraction tube is fixedly mounted on the lower end of the connector, the extraction tube is inserted into the storage tank, and the storage tank and the connector are threadedly connected.

[0013] Preferably, refrigeration fins are fixedly installed on the left and right sides of the interior of the installation groove, and arc-shaped structures that fit with the storage tank are provided on the side surfaces of the refrigeration fins.

[0014] Preferably, a docking block is fixedly installed on the side of the control box, and the docking block and the docking groove are engaged with each other, and the docking groove is provided on the outer surface of the lower ends of the first clamping rod and the second clamping rod.

[0015] Preferably, a first magnetic block is fixedly mounted on the outside of the side surface of the control box, and second magnetic blocks are fixedly mounted on the outer surfaces of the first clamping rod and the second clamping rod, and the first magnetic block and the second magnetic block are magnetically attracted to each other.

[0016] Preferably, an adhesive tape for adhering to the skin is fixedly installed on the outside of the applicator, and a hemostatic dressing is fixedly installed on the outer surface of the applicator, and the hemostatic dressing and the injection microneedle are located on the same side, the first clamping rod and the second clamping rod are rotatably connected by a connecting shaft, and the first clamping rod and the second clamping rod are both provided with through-type air holes, and a buffer sponge pad is fixedly installed on the inner surface of the lower end of the first clamping rod and the second clamping rod.

[0017] Preferably, the data learning module includes a hardware layer, a data layer and a system algorithm layer, wherein: Hardware layer: The light sensor array uses multispectral sensors to determine day and night and monitor ambient light intensity; Programmable microfluidic drug delivery device: i.e., a delivery pump (16) that supports timed quantitative control with an accuracy of ±0.1 mL; Bio-signal acquisition module: integrated heart rate and body motion sensors through flexible electronic skin patches; Edge computing unit: low-power MCU + Bluetooth 5.2 / Wi-Fi 6 dual-mode communication; Data layer: Dynamic data: light exposure time, movement trajectory, sleep quality score; Physiological data: circadian rhythm characteristics, drug metabolism rate models; Environmental data: geographical location lighting history database; Intelligent algorithm layer: Time series prediction model: Transformer architecture processes multimodal time series data; Reinforcement learning engine: optimizes drug delivery strategies based on the PPO algorithm; Anomaly detection module: Isolation forest algorithm identifies sudden changes in work and rest schedules; The light sensor 6 collects ambient light intensity and infrared spectrum characteristics every five minutes and determines the day and night state through multi-spectral analysis: Daytime mode: visible light > 2000 lux and infrared band conforms to the characteristics of the solar spectrum; Dawn-to-dusk transition: infrared signature matching sunrise / sunset database (compared with historical lighting data of GPS location); Night mode: Visible light <50 lux and no artificial light source characteristics (such as the absence of LED blue light peak).

[0018] Afterwards, the patient's body movement frequency and heart rate variability are monitored in conjunction with biological signal collection (electrode patches, data transmitted via Bluetooth).

[0019] Finally, the data will be transmitted to the cloud-based big data learning server to build a specific personal biological clock model for the patient, achieving a more accurate drug administration effect.

[0020] Compared with the prior art, the beneficial effects of the present invention are as follows: the wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint adopts a novel structural design, and its specific contents are as follows: 1. The device is worn on the patient's head using a head clip, and the applicator is attached to the face at the corresponding jaw joint position using an adhesive tape. The drug in the storage tank is then delivered to the applicator through the first and second connecting tubes by a delivery pump, and then injected into the body through the injection microneedle to achieve the purpose of treatment; Furthermore, a light sensor is provided on the outer surface of the control box. The light sensor can sense the intensity of the surrounding light, thereby determining whether it is daytime or nighttime. The light sensor transmits a signal to the control chip, which automatically controls the delivery pump to administer the drug. During the day, when metabolism is strong, a large amount of drug is administered, while at night, when metabolism is weak, the amount of drug is reduced, ultimately achieving the best therapeutic effect. The data learning module divides light-controlled drug delivery into three intervals: morning drug delivery (06:00-09:00): increases the dose of neuroleptic drugs by 10-15% (using sunlight to promote absorption); dusk transition (18:00-20:00): activates the sustained-release module to match the melatonin secretion curve; late night mode (00:00-05:00): triggers vibration reminders and micro-dosing to prevent concentration surges. The specific dosage is automatically adjusted based on the patient's learned sleep and rest habits. Furthermore, the storage tank is disassembled and installed between the mounting groove and the connector through a threaded connection. The extraction tube at the lower end of the connector is inserted into the storage tank and cooperates with the delivery pump to achieve the purpose of extracting the medicine. A refrigeration plate is fixedly installed on the inner wall of the mounting groove, and the refrigeration plate is used to cool the medicine in the storage tank, thereby avoiding the decline of the medicine's medicinal properties.

[0021] 2. The docking block fixedly installed on the side of the control box is used to engage with the docking groove to install the control box to the lower ends of the first clamping rod and the second clamping rod. During installation, the magnetic attraction between the first magnetic block and the second magnetic block is used to further secure the control box and prevent it from falling off during use. Furthermore, the first clamp rod and the second clamp rod are rotated with each other using the connecting shaft at the top, and the connecting spring at the upper end can adapt to patients with different head sizes. A buffer sponge pad is fixedly installed on the inner side of the lower end of the first clamp rod and the second clamp rod. The buffer sponge pad can reduce the pressure of the wearable device on the head and improve wearing comfort. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 It is a schematic diagram of the overall structure of the present invention; Figure 2 This is a structural schematic diagram of the connection relationship between the first clamping rod and the second clamping rod of the present invention; Figure 3 This is a schematic structural diagram of the drug delivery device of the present invention; Figure 4 This is a schematic structural diagram of the connection relationship between the control box and the first clamping rod of the present invention; Figure 5 This is a structural diagram of the docking block of the present invention; Figure 6 This is a schematic diagram of the internal structure of the control box of the present invention; Figure 7 For the present invention Figure 6 A in the middle is an enlarged structural diagram; Figure 8 This is a schematic diagram of the extraction tube structure of the present invention; Figure 9 This is a schematic diagram of the structure of the refrigeration plate of the present invention; Figure 10 This is the main control system flow chart of the present invention.

[0023] In the figure: 1. Wearable head clip; 101. First clamping rod; 102. Second clamping rod; 2. Connecting spring; 3. Ventilation hole; 4. Control box; 5. Operation button; 6. Light sensor; 7. Mounting slot; 8. Storage tank; 9. First connecting pipe; 10. Applicator; 11. Injection microneedle; 12. Adhesive tape; 13. Hemostatic dressing; 14. Lithium battery; 15. Charging port; 16. Delivery pump; 17. Connector; 18. Second connecting pipe; 19. Extraction tube; 20. Refrigeration plate; 21. Control chip; 22. Signal transmitter; 23. Connecting shaft; 24. Buffer sponge pad; 25. Docking block; 26. Docking slot; 27. First magnetic block; 28. Second magnetic block. DETAILED DESCRIPTION

[0024] The following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.

[0025] Example 1: Please refer to Figure 1-Figure 3 and Figures 6-10In order to solve the problem that traditional devices cannot be automatically controlled, this embodiment provides the following technical solutions, which specifically discloses: a wearable head clamp 1 worn on the patient's head, a connecting spring 2 is fixedly installed on the upper surface of the wearable head clamp 1, the wearable head clamp 1 is divided into a first clamping rod 101 and a second clamping rod 102 that are symmetrical to each other, and a control box 4 is installed on the side of the first clamping rod 101 and the second clamping rod 102, and an operation button 5 and a light sensor 6 are fixedly installed on the outer surface of the control box 4, and the light sensor 6 cooperates with the intelligent control system inside the control box 4 for control, a lithium battery 14 for powering other components is fixedly installed on the upper end of the control box 4, and a charging port 15 for charging the lithium battery 14 is provided on the upper surface of the control box 4, and an installation groove 7 is provided at the lower end of the control box 4, a storage tank 8 for storing medicine is installed inside the installation groove 7, a first connecting tube 9 is fixedly installed on the outside of the control box 4, and a drug delivery device 10 corresponding to the position of the patient's jaw joint is fixedly installed on the lower end of the first connecting tube 9, and a matrix-arranged injection microneedle 11 is fixedly installed on the outside of the drug delivery device 10, and the intelligent control system The system includes a delivery pump 16, a control chip 21 and a signal transmitter 22 fixedly installed inside the control box 4, and the water outlet end of the delivery pump 16 is fixedly connected to the first connecting pipe 9, the light sensor 6 and the delivery pump 16 communicate with each other through the cable and the control chip 21, and the signal transmitter 22 communicates with the wireless terminal through 5G signals. The wireless terminal is the patient's personal mobile phone. A connector 17 corresponding to the mounting slot 7 is fixedly installed in the middle position inside the control box 4, and the connector 17 is connected to the second connecting pipe 18 at its upper end. The water inlet end of the delivery pump 16 is connected, an extraction tube 19 is fixedly installed at the lower end of the connector 17, and the extraction tube 19 is inserted into the storage tank 8, and the storage tank 8 and the connector 17 are threadedly connected, and cooling plates 20 are fixedly installed on the left and right sides of the installation groove 7, and the side of the cooling plate 20 is provided with an arc structure that fits with the storage tank 8, an adhesive tape 12 for sticking to the skin is fixedly installed on the outside of the applicator 10, and a hemostatic dressing 13 is fixedly installed on the outer surface of the applicator 10, and the hemostatic dressing 13 and the injection microneedle 11 are located on the same side.

[0026] When using the device, first wear the head clip 1 to the patient's head, and then use the adhesive tape 12 to fix the applicator 10 to the patient's face (the applicator 10 corresponds to the patient's jaw joint position, and the injection microneedle 11 on the outside of the applicator 10 penetrates the facial muscles, and the hemostatic patch 13 is used to achieve the purpose of hemostasis when the injection microneedle 11 penetrates). Then the doctor adjusts the use parameters of the device through the operation button 5 on the outside of the control box 4 (a lithium battery 14 is installed inside the control box 4, and the device is powered by the lithium battery 14, and the lithium battery 14 is charged through the charging port 15). Then the photosensor 6 detects the intensity of the ambient light, and the light data detected by the photosensor 6 is transmitted to the control chip 21, and the control chip 21 is used to determine whether it is Whether you turn off the lights and go to bed during the day or at night, the control chip 21 controls the delivery pump 16 to start. At this time, the delivery pump 16 extracts the medicine from the second connecting tube 18 and the storage tank 8, and then uses the first connecting tube 9 to deliver the medicine to the drug dispenser 10, and finally injects the medicine into the body through the injection microneedle 11. During this process, the extraction tube 19 at the lower end of the connector 17 is inserted into the storage tank 8 (the extraction tube 19 is connected to the second connecting tube 18, and the storage tank 8 is threadedly connected to the connector 17 through the threaded structure at its upper end, thereby achieving the purpose of free disassembly and installation from the mounting groove 7). At the same time, the refrigeration plates 20 fixedly installed on the left and right sides of the mounting groove 7 use the refrigeration plates 20 to cool the medicine in the storage tank 8 to prevent the medicine from deteriorating over a long period of time.

[0027] Example 2: Please refer to Figure 4-Figure 5 This embodiment provides the following technical solution, which specifically discloses: a docking block 25 is fixedly installed on the side of the control box 4, and the docking block 25 and the docking groove 26 are engaged with each other, and the docking groove 26 is opened on the outer surface of the lower end of the first clamping rod 101 and the second clamping rod 102, a first magnetic block 27 is fixedly installed on the outside of the side of the control box 4, and a second magnetic block 28 is fixedly installed on the outer surface of the first clamping rod 101 and the second clamping rod 102, and the first magnetic block 27 and the second magnetic block 28 are magnetically adsorbed to each other.

[0028] The outer surface of the control box 4 is fixedly installed with a docking block 25, and the control box 4 is installed by correspondingly engaging between the docking block 25 and the docking groove 26 (the docking groove 26 is provided on the outer surface of the lower end of the first clamping rod 101 and the second clamping rod 102). In this process, the magnetic adsorption effect between the first magnetic block 27 and the second magnetic block 28 is used to achieve the purpose of further fixation to avoid falling during use.

[0029] Example 3: Please refer to Figure 2In order to adapt to patients with different head sizes, this embodiment provides the following technical solutions, which specifically disclose: the first clamping rod 101 and the second clamping rod 102 are rotatably connected by a connecting shaft 23, and the first clamping rod 101 and the second clamping rod 102 are both provided with through-type air holes 3, and the inner surfaces of the lower ends of the first clamping rod 101 and the second clamping rod 102 are fixedly installed with buffer sponge pads 24.

[0030] The wearable head clamp 1 is configured as two parts, a first clamping rod 101 and a second clamping rod 102. The first clamping rod 101 and the second clamping rod 102 are rotatably connected via a connecting shaft 23 at the upper end. They can be rotated and opened when worn, and then cooperate with the connecting spring 2 above to achieve the purpose of clamping and fixing. This structure can be adapted to patients with different head sizes, and the buffer sponge pads 24 at the lower ends of the first clamping rod 101 and the second clamping rod 102 utilize their own elastic action to reduce the wearing pressure and improve wearing comfort.

[0031] Example 4: A data learning module is set between the photosensor 6 and the control box 4. The data learning module cooperates with the photosensor 6 to automatically adjust the specific dosage according to the patient's learned work and rest habits (i.e., the biological clock set for the patient by the cloud big data server). Specifically: The data learning module includes a hardware layer, a data layer, and a system algorithm layer. The hardware layer uses a multispectral sensor to determine day and night and monitor the ambient light intensity, and the data layer performs data comparison. Finally, the system algorithm layer constructs a patient-specific personal circadian clock model. The learning module then uses the circadian clock to intelligently control the delivery pump 16 (at this time, the photosensor 6 determines whether the surrounding environment is daytime or nighttime, and thus provides different dosage instructions according to the established circadian clock), achieving a more accurate drug delivery effect. The data learning module includes a hardware layer, a data layer, and a system algorithm layer, in which: Hardware layer: 6-photosensor array uses multispectral sensors to determine day and night and monitor ambient light intensity; programmable microfluidic drug delivery device: 16 delivery pumps, supporting timed and quantitative control with an accuracy of ±0.1mL; biosignal acquisition module: integrated heart rate and body motion sensors through a flexible electronic skin patch; edge computing unit: low-power MCU + Bluetooth 5.2 / Wi-Fi 6 dual-mode communication; Data layer: dynamic data: light exposure time, movement trajectory, sleep quality score; physiological data: circadian rhythm characteristics, drug metabolism rate model; environmental data: geographical location light history database; intelligent algorithm layer: time series prediction model: Transformer architecture processes multimodal time series data; reinforcement learning engine: optimizes drug administration strategy based on PPO algorithm; anomaly detection module: isolation forest algorithm identifies sudden changes in work and rest schedule.

[0032] The light sensor 6 collects ambient light intensity and infrared spectrum characteristics every five minutes and determines the day and night state through multi-spectral analysis: Daytime mode: visible light > 2000 lux and infrared band conforms to the characteristics of the solar spectrum; Dawn-to-dusk transition: infrared signature matching sunrise / sunset database (compared with historical lighting data of GPS location); Night mode: Visible light <50 lux and no artificial light source characteristics (such as the absence of LED blue light peak).

[0033] Afterwards, the patient's body movement frequency and heart rate variability are monitored in conjunction with biological signal collection (electrode patches, data transmitted via Bluetooth).

[0034] Finally, the data will be transmitted to the cloud-based big data learning server to build a specific personal biological clock model for the patient, achieving a more accurate drug administration effect.

[0035] In the description of the present invention, unless otherwise specified, "plurality" means two or more; terms such as "upper," "lower," "left," "right," "inner," "outer," "front end," "rear end," "head," and "tail" indicate positions or relationships based on those shown in the accompanying drawings. These terms are intended solely to facilitate the description of the present invention and simplify the description. They do not indicate or imply that the devices or components referred to must have a specific orientation, be constructed, or operate in a specific orientation. Therefore, they should not be construed as limiting the present invention. Furthermore, terms such as "first," "second," and "third" are used for descriptive purposes only and should not be construed as indicating or implying relative importance.

[0036] While embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions, and variations may be made to these embodiments without departing from the principles and spirit of the invention, and that the scope of the invention is defined by the appended claims and their equivalents.

Claims

1. A wearable light-controlled controlled-release drug delivery device for treating temporomandibular joint, comprising a wearable head clip (1) worn on the patient's head, wherein a connecting spring (2) is fixedly mounted on the upper surface of the wearable head clip (1), and characterized in that: The wearable head clamp (1) is divided into a first clamping rod (101) and a second clamping rod (102) which are symmetrical to each other, and a control box (4) is installed on the side of each of the first clamping rod (101) and the second clamping rod (102), and an operating button (5) and a light sensor (6) are fixedly installed on the outer surface of the control box (4), and the light sensor (6) cooperates with the intelligent control system inside the control box (4) for control; A lithium battery (14) for supplying power to other components is fixedly mounted on the upper end of the control box (4), and a charging port (15) for charging the lithium battery (14) is provided on the upper surface of the control box (4), and a mounting groove (7) is provided at the lower end of the control box (4), and a storage tank (8) for storing medicine is installed inside the mounting groove (7); A first connecting tube (9) is fixedly mounted on the outside of the control box (4), and a drug delivery device (10) corresponding to the position of the patient's jaw joint is fixedly mounted on the lower end of the first connecting tube (9), and injection microneedles (11) arranged in a matrix are fixedly mounted on the outside of the drug delivery device (10).

2. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 1, characterized in that: The intelligent control system comprises a delivery pump (16), a control chip (21) and a signal transmitter (22) fixedly mounted inside the control box (4), and a water outlet end of the delivery pump (16) is fixedly connected to the first connecting pipe (9).

3. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 2, characterized in that: The photosensor (6) and the delivery pump (16) communicate with each other via a flat cable and a control chip (21), and the signal transmitter (22) communicates with a wireless terminal via a 5G signal, and the wireless terminal is a patient's personal mobile phone.

4. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 1, characterized in that: A connector (17) corresponding to the mounting groove (7) is fixedly installed in the middle position inside the control box (4), and the connector (17) is connected to the water inlet end of the delivery pump (16) through a second connecting pipe (18) at its upper end.

5. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 4, characterized in that: An extraction tube (19) is fixedly mounted on the lower end of the connector (17), and the extraction tube (19) is inserted into the interior of the storage tank (8), and the storage tank (8) and the connector (17) are threadedly connected.

6. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 5, characterized in that: Refrigeration fins (20) are fixedly installed on the left and right sides of the interior of the installation groove (7), and the sides of the refrigeration fins (20) are provided with arc-shaped structures that fit the storage tank (8).

7. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 1, characterized in that: A docking block (25) is fixedly mounted on the side of the control box (4), and the docking block (25) and the docking groove (26) are mutually engaged and mounted, and the docking groove (26) is provided on the outer surface of the lower ends of the first clamping rod (101) and the second clamping rod (102).

8. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 7, characterized in that: A first magnetic block (27) is fixedly mounted on the outside of the side of the control box (4), and second magnetic blocks (28) are fixedly mounted on the outer surfaces of the first clamping rod (101) and the second clamping rod (102), and the first magnetic block (27) and the second magnetic block (28) are magnetically attracted to each other.

9. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 1, characterized in that: The applicator (10) is fixedly provided with an adhesive tape (12) for adhering to the skin on the outside, and a hemostatic dressing (13) is fixedly provided on the outer surface of the applicator (10), and the hemostatic dressing (13) and the injection microneedle (11) are located on the same side; the first clamping rod (101) and the second clamping rod (102) are rotatably connected by a connecting shaft (23), and a through-type air vent (3) is provided inside the first clamping rod (101) and the second clamping rod (102), and a buffer sponge pad (24) is fixedly provided on the inner surface of the lower end of the first clamping rod (101) and the second clamping rod (102).

10. The wearable light-controlled controlled-release drug delivery device for treating the temporomandibular joint according to claim 1, characterized in that: A data learning module is provided between the photosensor (6) and the control box (4), and the data learning module cooperates with the photosensor (6) to automatically adjust the specific medication amount according to the learned patient's daily habits; The data learning module consists of hardware, data, and system algorithm layers. The hardware layer uses a multispectral sensor to determine daytime and nighttime and monitor ambient light intensity. The data layer then performs data comparisons. Finally, the system algorithm layer constructs a patient-specific circadian clock model to achieve more precise drug delivery. Among them: The hardware layer includes: The light sensor array uses multispectral sensors to determine day and night and monitor ambient light intensity; Programmable microfluidic drug delivery device: i.e., a delivery pump (16) that supports timed quantitative control with an accuracy of ±0.1 mL; Bio-signal acquisition module: integrated heart rate and body motion sensors through flexible electronic skin patches; Edge computing unit: low-power MCU + Bluetooth 5.2 / Wi-Fi 6 dual-mode communication; The data layer includes: Dynamic data: light exposure time, movement trajectory, sleep quality score; Physiological data: circadian rhythm characteristics, drug metabolism rate models; Environmental data: geographical location lighting history database; The intelligent algorithm layer includes: Time series prediction model: Transformer architecture processes multimodal time series data; Reinforcement learning engine: optimizes drug delivery strategies based on the PPO algorithm; Anomaly detection module: Isolation forest algorithm identifies sudden changes in work and rest schedules.

Images